Anti–GM-CSF Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial
Am J Respir Crit Care Med 2022 Jun 01;205(11)1290-1299, GJ Criner, FM Lang, RL Gottlieb, KS Mathews, TS Wang, TW Rice, D Madduri, S Bellam, R Jeanfreau, AH Case, MK Glassberg, GM Lyon, K Ahmad, R Mendelson, JM DiMaio, MP Tran, CW Spak, JA Abbasi, SG Davis, S Ghamande, S Shen, L Sherman, S LowryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.